Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapy-Reference-Cited by-同舟云学术

Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapy

Published:1995-05 Issue:5 Volume:21 Page:917-927
ISSN:0309-2402
Container-title:Journal of Advanced Nursing
language:en
Short-container-title:J Adv Nurs

Author:

Gardulf Ann,Bjorvell Hjordis,Andersen Vagn,Bjorkander Janne,Ericson Diddi,Froland Stig S.,Gustafson Rolf,Hammarstrom Lennart,Nystrom Tiina,Soeberg Bjorn,Smith C.I. Edvard

Publisher

Wiley

Subject

General Nursing

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2648.1995.21050917.x/fullpdf

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-reported preferences for subcutaneous or intravenous administration of parenteral drug treatments in adults with immune disorders: a systematic review and meta-analysis;Journal of Comparative Effectiveness Research;2024-09

2. Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use;Cells;2023-10-07

3. Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens;Journal of Clinical Immunology;2023-05-09

4. Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience With Enhanced Infusion Regimens;2023-03-24

5. Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency;Expert Review of Clinical Immunology;2022-11-15